Advertisement
UK markets close in 4 hours 43 minutes

  • FTSE 100

    8,105.78
    +26.92 (+0.33%)
     

  • FTSE 250

    19,815.97
    +213.99 (+1.09%)
     

  • AIM

    755.57
    +2.45 (+0.33%)
     

  • GBP/EUR

    1.1658
    +0.0002 (+0.02%)
     

  • GBP/USD

    1.2512
    +0.0001 (+0.01%)
     

  • Bitcoin GBP

    51,373.36
    +596.40 (+1.17%)
     

  • CMC Crypto 200

    1,388.45
    -8.09 (-0.58%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • DOW

    38,085.80
    -375.12 (-0.98%)
     

  • CRUDE OIL

    83.94
    +0.37 (+0.44%)
     

  • GOLD FUTURES

    2,359.20
    +16.70 (+0.71%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • HANG SENG

    17,651.15
    +366.61 (+2.12%)
     

  • DAX

    18,052.50
    +135.22 (+0.75%)
     

  • CAC 40

    8,035.90
    +19.25 (+0.24%)
     
PROPERTY:

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

BTG unit pleads guilty in U.S. to misbranding, to pay $36 mln

Reuters - UK Focus

Nov 7 (Reuters) - A U.S. unit of British drug company BTG Plc pleaded guilty on Monday to a misdemeanor related to its misbranding of the embolic device LC Bead, and will pay about $36 million to resolve its criminal and civil liability, the U.S. Department of Justice said.

The plea agreement for BTG (Frankfurt: 908827 - news) 's Biocompatibles Inc unit was filed with the federal court in Washington, D.C., the Justice Department said. (Reporting by Jonathan Stempel in New York; Editing by Bernadette Baum)